AT376879B - Verfahren zur herstellung einer injektionsloesung - Google Patents

Verfahren zur herstellung einer injektionsloesung

Info

Publication number
AT376879B
AT376879B AT392982A AT392982A AT376879B AT 376879 B AT376879 B AT 376879B AT 392982 A AT392982 A AT 392982A AT 392982 A AT392982 A AT 392982A AT 376879 B AT376879 B AT 376879B
Authority
AT
Austria
Prior art keywords
producing
injection solution
injection
solution
Prior art date
Application number
AT392982A
Other languages
English (en)
Other versions
ATA392982A (de
Inventor
Ludwig H Dr Schlager
Original Assignee
Gerot Pharmazeutika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerot Pharmazeutika filed Critical Gerot Pharmazeutika
Priority to AT392982A priority Critical patent/AT376879B/de
Priority to LU85040A priority patent/LU85040A1/xx
Priority to DE19833337304 priority patent/DE3337304A1/de
Priority to NL8303549A priority patent/NL8303549A/nl
Priority to FR8316819A priority patent/FR2535205B1/fr
Priority to CH580983A priority patent/CH657525A5/de
Priority to BE0/211771A priority patent/BE898082A/fr
Publication of ATA392982A publication Critical patent/ATA392982A/de
Application granted granted Critical
Publication of AT376879B publication Critical patent/AT376879B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT392982A 1982-10-27 1982-10-27 Verfahren zur herstellung einer injektionsloesung AT376879B (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AT392982A AT376879B (de) 1982-10-27 1982-10-27 Verfahren zur herstellung einer injektionsloesung
LU85040A LU85040A1 (de) 1982-10-27 1983-10-07
DE19833337304 DE3337304A1 (de) 1982-10-27 1983-10-13 Injektionsloesung und verfahren zu deren herstellung
NL8303549A NL8303549A (nl) 1982-10-27 1983-10-14 Injectieoplossing en werkwijze voor het bereiden daarvan.
FR8316819A FR2535205B1 (fr) 1982-10-27 1983-10-21 Solution pour injection a base de substances antirhumatismales et d'une cobalamine et procede pour sa preparation
CH580983A CH657525A5 (de) 1982-10-27 1983-10-26 Verfahren zur herstellung einer injektionsloesung.
BE0/211771A BE898082A (fr) 1982-10-27 1983-10-26 Solution pour injection et procede pour sa preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT392982A AT376879B (de) 1982-10-27 1982-10-27 Verfahren zur herstellung einer injektionsloesung

Publications (2)

Publication Number Publication Date
ATA392982A ATA392982A (de) 1984-06-15
AT376879B true AT376879B (de) 1985-01-10

Family

ID=3557346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT392982A AT376879B (de) 1982-10-27 1982-10-27 Verfahren zur herstellung einer injektionsloesung

Country Status (7)

Country Link
AT (1) AT376879B (de)
BE (1) BE898082A (de)
CH (1) CH657525A5 (de)
DE (1) DE3337304A1 (de)
FR (1) FR2535205B1 (de)
LU (1) LU85040A1 (de)
NL (1) NL8303549A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
US5962536A (en) * 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
DE102007012644A1 (de) 2007-03-16 2008-09-18 Bayer Healthcare Ag Stabilisierung von Vitamin B12
EP2632430B1 (de) * 2010-10-29 2018-06-06 Troikaa Pharmaceuticals Ltd Zusammensetzungen zur nasalen verabreichung von vitamin b12

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1249453B (de) * 1963-10-14
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
GB1076670A (en) * 1964-11-02 1967-07-19 Chugai Pharmaceutical Co Ltd A stabilised aqueous hydroxo cobalamin solution
DE2103387A1 (en) * 1971-01-26 1972-08-17 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Compns of glucosamine hydrochloride and anti-rheumatic - agent - for treatment of arthrosis and arthritis,with reduced toxicit
AU485607B2 (en) * 1972-12-04 1975-04-24 Ici Australia Limited Compositions
AT345447B (de) * 1975-05-17 1978-09-11 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von stabilen, injizierbaren, vitamin b12 und entzuendungshemmer enthaltenden arzneimitteln
JPS54151668A (en) * 1978-05-22 1979-11-29 Teijin Ltd Production of fluffed fabric
JPS5675438A (en) * 1979-11-22 1981-06-22 Senjiyu Seiyaku Kk Method for stabilizing aqueous solution of cyanocobalamin
US4337246A (en) * 1979-11-22 1982-06-29 Eisai Co., Ltd. Solid preparation comprising cobamamide or mecobalamin
EP0055118A1 (de) * 1980-12-19 1982-06-30 Wallace Lysaght Behandlung von Arthritis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU80432A1 (de) * 1978-10-26 1979-03-19 Hoffmann K Verfahren zum herstellen einer injektionsloesung,die mono-phenylbutazon enthaelt,und injektionsloesung,hergestellt nach diesem verfahren

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
DE1249453B (de) * 1963-10-14
GB1076670A (en) * 1964-11-02 1967-07-19 Chugai Pharmaceutical Co Ltd A stabilised aqueous hydroxo cobalamin solution
DE2103387A1 (en) * 1971-01-26 1972-08-17 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Compns of glucosamine hydrochloride and anti-rheumatic - agent - for treatment of arthrosis and arthritis,with reduced toxicit
AU485607B2 (en) * 1972-12-04 1975-04-24 Ici Australia Limited Compositions
AT345447B (de) * 1975-05-17 1978-09-11 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von stabilen, injizierbaren, vitamin b12 und entzuendungshemmer enthaltenden arzneimitteln
JPS54151668A (en) * 1978-05-22 1979-11-29 Teijin Ltd Production of fluffed fabric
JPS5675438A (en) * 1979-11-22 1981-06-22 Senjiyu Seiyaku Kk Method for stabilizing aqueous solution of cyanocobalamin
US4337246A (en) * 1979-11-22 1982-06-29 Eisai Co., Ltd. Solid preparation comprising cobamamide or mecobalamin
EP0055118A1 (de) * 1980-12-19 1982-06-30 Wallace Lysaght Behandlung von Arthritis

Also Published As

Publication number Publication date
BE898082A (fr) 1984-02-15
LU85040A1 (de) 1984-03-22
ATA392982A (de) 1984-06-15
NL8303549A (nl) 1984-05-16
DE3337304A1 (de) 1984-05-03
FR2535205B1 (fr) 1987-02-06
FR2535205A1 (fr) 1984-05-04
CH657525A5 (de) 1986-09-15

Similar Documents

Publication Publication Date Title
AT382780B (de) Verfahren zur herstellung einer insulinloesung
AT375652B (de) Verfahren zur herstellung von arylaliphatischen polyisozyanuraten
AT385201B (de) Verfahren zur herstellung einer antiinflammatorischen ophthalmischen loesung
DE3381128D1 (de) Verfahren zur herstellung einer isolationszone.
ATA148982A (de) Verfahren zur herstellung einer analgetisch wirkenden zusammensetzung
AT374827B (de) Verfahren zur herstellung von cholesterase
AT377259B (de) Verfahren zur herstellung von dihydropyridylimidatestern
AT389512B (de) Verfahren zur herstellung von 3-chlormethylchinuclidin
AT367436B (de) Verfahren zur herstellung von copolymerisaten
AT379161B (de) Verfahren zur herstellung von elastomer-duromer-verbundteilen
AT376879B (de) Verfahren zur herstellung einer injektionsloesung
AT380480B (de) Verfahren zur herstellung von anthracyclinglykosiden
AT387770B (de) Verbessertes verfahren zur herstellung von trichlorisocyanursaeure
AT380686B (de) Verfahren zur herstellung von buspiron
ATA328780A (de) Verfahren zur herstellung acylaminobenzoesaeurecerivaten
AT378507B (de) Verfahren zur herstellung einer eierverpackung
AT375328B (de) Verfahren zur herstellung von sintermagnesia
AT388374B (de) Verfahren zur herstellung von n-sulfonylaryloxybenzamiden
ATA201283A (de) Verfahren zur herstellung von carboxyalkyldipeptiden
ATA110780A (de) Verfahren zur herstellung von o-trimethylsilyl- -cellulosen
ATA319282A (de) Verfahren zur herstellung von reinem 3-amino-crotonitril
AT378186B (de) Verfahren zur herstellung von cimetidin
ATA328581A (de) Verfahren zur herstellung von 1-phenoxy-3-amino- 2-propanolen
ATA535281A (de) Verfahren zur herstellung von phenoxyisobutters|ureestern
ATA81785A (de) Verfahren zur herstellung von anthracyclinglykosiden

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELA Expired due to lapse of time